239 related articles for article (PubMed ID: 38711119)
1. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
2. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism and functional role of brefeldin A-mediated ADP-ribosylation of CtBP1/BARS.
Colanzi A; Grimaldi G; Catara G; Valente C; Cericola C; Liberali P; Ronci M; Lalioti VS; Bruno A; Beccari AR; Urbani A; De Flora A; Nardini M; Bolognesi M; Luini A; Corda D
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9794-9. PubMed ID: 23716697
[TBL] [Abstract][Full Text] [Related]
4. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
5. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.
Deng Y; Deng H; Bi F; Liu J; Bemis LT; Norris D; Wang XJ; Zhang Q
Int J Biol Sci; 2011 Jan; 7(1):133-7. PubMed ID: 21278922
[TBL] [Abstract][Full Text] [Related]
7. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
8. Components of the CtBP1/BARS-dependent fission machinery.
Valente C; Luini A; Corda D
Histochem Cell Biol; 2013 Oct; 140(4):407-21. PubMed ID: 23996193
[TBL] [Abstract][Full Text] [Related]
9. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
10. Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.
Winklmeier A; Poser I; Hoek KS; Bosserhoff AK
BMC Cancer; 2009 Feb; 9():52. PubMed ID: 19216735
[TBL] [Abstract][Full Text] [Related]
11. Evidence that mono-ADP-ribosylation of CtBP1/BARS regulates lipid storage.
Bartz R; Seemann J; Zehmer JK; Serrero G; Chapman KD; Anderson RG; Liu P
Mol Biol Cell; 2007 Aug; 18(8):3015-25. PubMed ID: 17538025
[TBL] [Abstract][Full Text] [Related]
12. Assembly of human C-terminal binding protein (CtBP) into tetramers.
Bellesis AG; Jecrois AM; Hayes JA; Schiffer CA; Royer WE
J Biol Chem; 2018 Jun; 293(23):9101-9112. PubMed ID: 29700119
[TBL] [Abstract][Full Text] [Related]
13. The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS.
Liberali P; Kakkonen E; Turacchio G; Valente C; Spaar A; Perinetti G; Böckmann RA; Corda D; Colanzi A; Marjomaki V; Luini A
EMBO J; 2008 Apr; 27(7):970-81. PubMed ID: 18354494
[TBL] [Abstract][Full Text] [Related]
14. The Golgi mitotic checkpoint is controlled by BARS-dependent fission of the Golgi ribbon into separate stacks in G2.
Colanzi A; Hidalgo Carcedo C; Persico A; Cericola C; Turacchio G; Bonazzi M; Luini A; Corda D
EMBO J; 2007 May; 26(10):2465-76. PubMed ID: 17431394
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional co-repressor C-terminal binding protein (CtBP) associates with centrosomes during mitosis.
Spyer M; Allday MJ
Cell Cycle; 2006 Mar; 5(5):530-7. PubMed ID: 16481748
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA485-3p negatively regulates the transcriptional co-repressor
Du K; Zhang X; Lou Z; Guo P; Zhang F; Wang B; Chen L; Zhang C
Int J Biol Sci; 2018; 14(11):1445-1456. PubMed ID: 30262996
[TBL] [Abstract][Full Text] [Related]
17. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
18. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.
Deng H; Liu J; Deng Y; Han G; Shellman YG; Robinson SE; Tentler JJ; Robinson WA; Norris DA; Wang XJ; Zhang Q
J Invest Dermatol; 2013 May; 133(5):1294-301. PubMed ID: 23303449
[TBL] [Abstract][Full Text] [Related]
19. NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
Nichols JC; Schiffer CA; Royer WE
J Biol Chem; 2021; 296():100351. PubMed ID: 33524397
[TBL] [Abstract][Full Text] [Related]
20. CtBPs promote cell survival through the maintenance of mitotic fidelity.
Bergman LM; Birts CN; Darley M; Gabrielli B; Blaydes JP
Mol Cell Biol; 2009 Aug; 29(16):4539-51. PubMed ID: 19506021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
